BALTIMORE, October 24, 2025--(BUSINESS WIRE)--Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today ...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Franklin Mountain Medical announced today that the company has received FDA clearance of its patented UltraNav Transseptal Catheter System for controlled access and ...

BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative ...

Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) clearance from the FDA.

Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has received 510(k) clearance from ...

TORONTO, Nov. 5, 2019 /PRNewswire/ - A randomized controlled trial has found that use of Baylis Medical's NRG® Transseptal Needle results in shorter time in achieving transseptal access, less ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The VersaCross™ Transseptal Solution is available in Pigtail and J-tip RF wire configurations. (CNW Group/Baylis Medical Company Inc.) TORONTO, Nov. 20, 2019 /PRNewswire/ - Baylis Medical announced ...